Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (51-60 of 672) with videos related to

Pageof 68
Sort By:
Rheumatology International|November 25, 2021
Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology departmentElodie Portier, Maxime Dougados, Anna Moltó
Rheumatology (Oxford, England)|April 3, 2010
Evaluation of the treatment effect of NSAIDs/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysisCécile Escalas, Sophie Trijau, Maxime Dougados
Contemporary Clinical Trials|March 30, 2021
Design and analysis considerations for first treatment escalation in clinical trialsWei Wei, Maxime Dougados, Corrado Bernasconi
RMD Open|October 29, 2015
Patient-reported outcomes as end points in clinical trials in rheumatoid arthritisLaure Gossec, Maxime Dougados, William Dixon
Annals of the Rheumatic Diseases|June 16, 2016
Response to: 'Additional proposals to reduce comorbidity in patients with chronic inflammatory rheumatic diseases'. Screening for comorbidities: what is the remit of rheumatologists?Athan Baillet, Laure Gossec, Maxime Dougados
The Journal of Rheumatology|July 18, 2006
Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problemMartin Soubrier, Djamila Zerkak, Maxime Dougados
Rheumatology (Oxford, England)|December 24, 2009
Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive proteinMathilde Benhamou, Laure Gossec, Maxime Dougados
The Journal of Rheumatology|April 17, 2019
Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA StudyClementina López-Medina, Anna Moltó, Maxime Dougados
Arthritis Care & Research|April 15, 2010
Reliability of ultrasonography to detect synovitis in rheumatoid arthritis: a systematic literature review of 35 studies (1,415 patients)Peter P Cheung, Maxime Dougados, Laure Gossec
Arthritis and Rheumatism|July 13, 2002
Sample sizes estimated in clinical trials using either a composite index (ASAS response criteria) or single outcome variables in ankylosing spondylitisGuy-Robert Auleley, Maxime Dougados, Gabrial Baron
Pageof 68

Showing results (51-60 of 672) with videos related to

Sort By:
Pageof 68
Rheumatology International|November 25, 2021
Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology departmentElodie Portier, Maxime Dougados, Anna Moltó
Rheumatology (Oxford, England)|April 3, 2010
Evaluation of the treatment effect of NSAIDs/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysisCécile Escalas, Sophie Trijau, Maxime Dougados
Contemporary Clinical Trials|March 30, 2021
Design and analysis considerations for first treatment escalation in clinical trialsWei Wei, Maxime Dougados, Corrado Bernasconi
RMD Open|October 29, 2015
Patient-reported outcomes as end points in clinical trials in rheumatoid arthritisLaure Gossec, Maxime Dougados, William Dixon
Annals of the Rheumatic Diseases|June 16, 2016
Response to: 'Additional proposals to reduce comorbidity in patients with chronic inflammatory rheumatic diseases'. Screening for comorbidities: what is the remit of rheumatologists?Athan Baillet, Laure Gossec, Maxime Dougados
The Journal of Rheumatology|July 18, 2006
Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problemMartin Soubrier, Djamila Zerkak, Maxime Dougados
Rheumatology (Oxford, England)|December 24, 2009
Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive proteinMathilde Benhamou, Laure Gossec, Maxime Dougados
The Journal of Rheumatology|April 17, 2019
Peripheral Manifestations in Spondyloarthritis and their Effect: An Ancillary Analysis of the ASAS-COMOSPA StudyClementina López-Medina, Anna Moltó, Maxime Dougados
Arthritis Care & Research|April 15, 2010
Reliability of ultrasonography to detect synovitis in rheumatoid arthritis: a systematic literature review of 35 studies (1,415 patients)Peter P Cheung, Maxime Dougados, Laure Gossec
Arthritis and Rheumatism|July 13, 2002
Sample sizes estimated in clinical trials using either a composite index (ASAS response criteria) or single outcome variables in ankylosing spondylitisGuy-Robert Auleley, Maxime Dougados, Gabrial Baron
Pageof 68